Codexis to Hold First Quarter 2020 Conference Call on May 7
04/30/2020 - 07:00 AM
REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after market close on Thursday, May 7, 2020. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
100%; border-collapse:collapse !important;">20%; width:20% ; min-width:20% ;"> 25%; width:25% ; min-width:25% ;"> 55%; width:55% ; min-width:55% ;"> Live Call: U.S. 855 890 8665 International 720 634 2938 Passcode 6668354 Live Webcast: Codexis IR Website The webcast will be archived for 90 days. Replay: U.S. 855 859 2056 International 404 537 3406 Passcode 6668354 The replay will be available for 48 hours
About Codexis, Inc.
Codexis is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, fine chemicals and industrial enzymes, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables improvements in protein performance, meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial-scale implementations of biocatalytic processes. For more information, see www.codexis.com .
Contact: jcain@lhai.com
CDXS Rankings
#5181 Ranked by Stock Gains
CDXS Stock Data
Industry
Paint and Coating Manufacturing
Sector
Manufacturing
Tags
Process Industries, Chemicals: Specialty, Manufacturing, Paint and Coating Manufacturing
Country
US
City
Portland
About CDXS
codexis, inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins™. our proprietary codeevolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. you get precisely the protein you need for the job you want it to do. guided by proprietary artificial intelligence software and advanced high-throughput screening systems, codexis is able to efficiently generate and introduce function-driven mutations to rapidly improve a protein for its target application. since 2002, codexis’ in-house biochemists, biologists and bioinformatics experts have worked closely with our clients to advance the technologies for protein optimization and production, enabling breakthrough develop
